電気生理市場:製品別(ラボデバイス(3Dマッピング、レコーディング)、アブレーションカテーテル(Cryoablation、RF)、診断用カテーテル(従来型、先進型、超音波))、適応症(AF、AVNRT、WPW)、エンドユーザー(病院、ASC) - 2027年までの世界市場予測Electrophysiology Market by Product (Lab Devices (3D Mapping, Recording), Ablation Catheters (Cryoablation, RF), Diagnostic Catheters (Conventional, Advanced, Ultrasound)), Indication (AF, AVNRT, WPW), End User (Hospitals, ASCs) - Global Forecasts to 2027 電気生理の世界市場は、2022年から2027年の予測期間中にCAGR9.4%で、2021年の68億米ドルから2027年には116億米ドルに達すると予測されます。 電気生理学(EP)検査は、複雑な心疾患を診断・治療するために、患... もっと見る
日本語のページは自動翻訳を利用し作成しています。
サマリー電気生理の世界市場は、2022年から2027年の予測期間中にCAGR9.4%で、2021年の68億米ドルから2027年には116億米ドルに達すると予測されます。電気生理学(EP)検査は、複雑な心疾患を診断・治療するために、患者の心臓の電気的活動や電気経路を調べるために実施されます。これにより、電気生理学者は心調律障害の原因を理解し、必要な治療法を提案することができます。電気生理学(EP)とは、心臓の電気的活動を分析・診断するために研究される心臓の電気システムのことである。心臓電気生理学では、侵襲的なカテーテルを用いて心臓の電気活動を記録し、その現象を研究する。この研究は、複雑な不整脈や心拍障害を評価するのに役立ちます。 電気生理学の世界市場の成長は、技術の進歩、市場への新規参入、投資、資金、助成金の増加、対象疾患や処置の発生率の増加などの要因によるものと思われます。また、新興国市場は、この市場で活動するプレーヤーに高い成長機会を提供すると期待されています。 WHOによると、CVDは世界における死因の第1位です。CVDや脳卒中の有病率上昇の主な要因としては、家族歴、民族性、年齢などが挙げられます。米国心臓協会によると、2030年までに米国成人の約41.4%が高血圧症になるとされています(2012年から8.4%の増加)。また、同団体は、CVDの世界的なコストは、2010年の8630億米ドルから2030年には1兆440億米ドルに達すると推定しています。2016年には、世界で〜1790万人がCVDで死亡しています。2030年には、この数は2,360万人に増加すると推定されています(出典:WHO)。 心房細動は、臨床現場で診断される最も一般的な不整脈であり、ヨーロッパでは毎年新たに88万6,000人以上が罹患しています。2030年には、心房細動の患者数は人口の70%まで増加すると予想されており、2050年には、ヨーロッパが最も心房細動の患者数が多くなると予想されています(出典:2018年心房細動の負担に関する報告書)。米国では、2012年に約270万人から610万人がAFの影響を受けましたが、2030年には1210万人に増加すると推定されています(出典:CDC)。2015年8月にMedical Journal of Australiaに掲載された研究によると、オーストラリアにおける55歳以上のAF患者数は2014年6月に328,562人であり、2034年には60万人以上に達すると推定されています。これらの疾患の発生率の上昇は、それに対応してEP処置の需要を促進し、電気生理学市場の主要な成長ドライバーとなります。例えば、世界のアブレーション施術数は2017年の973,220件から2022年には年間1,455,000件に増加すると予測されており、この中で複合アブレーション(AFおよびVT)は2017年の440,629件から2022年の830,390件へと毎年13%増加すると見込まれています(出典:バイオシグテクノロジー、年次報告、2019年)。 しかしながら、電気生理製品の高コスト、不適切な償還、米国における不利な医療改革、新製品上市のためのコスト高な臨床データの要求、代替技術の利用可能性などの要因が、今後数年間、この市場の成長を抑制すると予想されています。また、機器の再使用や再処理、熟練した電気生理専門医の不足なども、同市場の課題として挙げられます。また、COVID-19の大流行により、予測期間中に市場の成長が一時的に鈍化することが予想されます。 "2021年の電気生理検査装置部門が世界の電気生理検査市場で最大のシェアを占める" 電気生理の世界市場は、製品別にEP診断カテーテル、EPアブレーションカテーテル、EPラボラトリーデバイス、アクセスデバイス、その他の製品に大別される。 電気生理検査装置市場は、3Dマッピングシステム、電気生理検査記録システム、RFアブレーションシステム、心内エコー(ICE)超音波イメージングシステム、電気生理検査X線システム、その他の電気生理検査装置(MRIシステム、電気生理検査遠隔磁気・ロボットナビゲーションシステム)に区分されます。 2021年の電気生理学市場では、EPラボ機器分野が57.0%の最大シェアを占めた。このセグメントは、予測期間中にCAGR 10.6%で成長すると予測される。 このセグメントの大きなシェアは、技術的に高度な3Dマッピングシステムの発売に対する市場プレイヤーの注目度の高まり、新しい電気生理記録システムの開発に対する官民の資金提供の増加、RFアブレーション施術数の増加、他のアブレーション技術と比較したRFアブレーション施術の費用対効果、主要市場におけるこれらの製品の入手可能性の高まりに起因するものと考えられます。 "2021年のエンドユーザー別電気生理市場において、病院・心臓センター部門が最大の市場シェアを占める" エンドユーザーセグメントに基づき、電気生理学市場は病院&心臓センターと外来手術センターに区分されます。2021年の市場シェアは、病院&心臓センター部門が最大(92.53%)です。このエンドユーザーセグメントの大きなシェアは、主に病院内の大きなカトラボや電気生理ラボの存在、CVDの有病率の上昇、アブレーション施術数の増加などに起因しているものと思われます。 病院・心臓センター部門には、政府病院と民間病院の両方、および心臓疾患患者の治療を行う心臓センターが含まれます。電気生理学的処置のほとんどは、病院や心臓病センターの電気生理学(EP)ラボやカテーテルラボで実施されます。心臓疾患の患者に治療を提供する心臓センターの数は、世界中で急速に増加しています。例えば、2016年6月には、ヘルスサイエンスノース(カナダ)とグレーターサドベリー(カナダ)の循環器専門医のチームが協力し、心臓治療のための新しいワンストップセンターを立ち上げました。2016年10月には、米国のKare Partners Groupがインドのチャンディーガルで心臓専門治療センターを立ち上げました。こうした立ち上げは、電気生理学的機器の需要を促進することが期待されます。 "2021年の適応症タイプ別電気生理検査市場において、心房細動分野が最大のシェアを占める" 電気生理市場は、適応症の種類に基づいて、心房細動、房室結節性リエントリー頻拍(AVNRT)、ウォルフ・パーキンソン-ホワイト(WPW)症候群、心房粗動、その他の適応症に区分されます。心房細動の有病率の増加、心房細動に関連するアブレーション手術の増加、世界的な高齢化社会の急速な進展、心房細動の早期診断のための高度電気生理製品の開発などにより、今後、この市場セグメントの成長が期待されます。 2021年の電気生理学市場の適応症別では、心房細動市場が最大のシェアを占めています。心房粗動分野は、2021年の電気生理学世界市場において2番目に大きなシェアを占めると予測されます。 米国では、2019年に約530万人が心房細動を患っていると報告されています(出典:米国心臓協会)。2050年には、米国で約1,200万人が心房細動に罹患すると予想されています。欧州心臓病学会(ESC)の機関誌「EP Europace」に掲載された論文によると、EU地域の65歳以上の約760万人が2016年に心房細動を発症し、2060年には89%増の1440万人になるという。このような心房細動の有病率の増加により、心房細動アブレーションの実施件数が大幅に増加することが予想されます。 AFibの有病率の増加を受けて、多くの主要企業が抗不整脈薬(AAD)に対するカテーテルアブレーションの優位性をアピールするための研究を進めています。例えば、2019年11月、バイオセンス ウェブスターは新しい心房細動管理レポートを発表し、カテーテルアブレーションが薬物療法よりも心房細動の進行を遅らせる効果がほぼ10倍あることを強調している。 "地域別ではAPAC市場が予測期間中に最も高い成長率を記録する" 電気生理市場は、地域別に北米、欧州、アジア太平洋地域、中南米、中東・アフリカに区分されます。アジア太平洋地域は、予測期間中に最も高い成長を記録すると予想されます。アジア太平洋地域は、中国、インド、日本、韓国、オーストラリア、およびマレーシア、台湾、シンガポール、ニュージーランドなどのその他のアジア太平洋地域に区分されます。 中国とインドが最も高い成長率を占めると予想されます。これらの国では、ライフスタイルや食習慣の変化、ストレスの増加、喫煙や飲酒の習慣化などにより、肥満、心臓病、その他の慢性疾患など、健康に関連する問題が増加しています。また、人口の多さ、老年人口の増加、慢性疾患の増加、医療費の増加、インフラ整備のための医療改革、先端技術に対する需要の増加、有力企業による新興市場への注力の高まり、規制の緩さなどの要因も、この地域の電気生理機器の需要を促進しています。 しかし、先進的な製品の価格が高いこと、最新の心臓再同期技術に対応するためのインフラ整備が不十分であること、健康関連問題への意識が低いことなどが、この市場の成長を阻害すると予想されています。また、この地域のエンドユーザーの多くは予算が限られており、低価格の製品を選んでいることも、市場成長を阻む大きな要因となっています。 本レポートで参照した主な参加企業の内訳は以下のとおりです。 - 企業タイプ別ティア1~25%、ティア2~37%、ティア3~38%。 - 役職別Cレベル-34%、ディレクターレベル-35%、その他-31 - 地域別北米24%、欧州32%、アジア太平洋28%、中南米10%、中近東・アフリカ6 電気生理市場の有力企業には、アボット社(米国)、メドトロニック社(アイルランド)、ボストン・サイエンティフィック社(米国)、Koninklijke Philips N.V. (オランダ)、GEヘルスケア社(米国)、Siemens Healthcare GmbH(ドイツ)、Stereotaxis, Inc.社があります。(米国)、Merit Medical Systems(米国)、Atricure Inc.(米国)、APN Health, LLC(米国)、Osypka Medical(ドイツ)、日本ライフライン株式会社(米国)、Stereotaxis, Inc.(日本)、Johnson & Johnson(米国)、Biotronik(ドイツ)、MicroPort Scientific Corporation(中国)、Acutus Medical, Inc.(米国)。(米国)があります。 研究対象 本レポートでは、電気生理市場を製品タイプ、適応症タイプ、エンドユーザー、地域に基づいて調査しています。また、市場成長に影響を与える要因を取り上げ、市場における様々な機会や課題を分析し、市場リーダー向けの競争環境についても詳しく解説しています。さらに、個々の成長動向に関してマイクロマーケットを分析し、主要5地域(およびこれらの地域のそれぞれの国)に関して市場セグメントの収益を予測しています。 レポート購入の理由 本レポートは、既存企業だけでなく、新規参入企業や中小企業も市場の動向を把握することができ、ひいてはより大きな市場シェアを獲得するのに役立つものと思われます。本レポートを購入された企業は、以下の戦略の1つまたは複数を組み合わせて、市場での存在感を高めることができます。 本レポートでは、以下のポイントについて考察しています。 市場の浸透。電気生理学市場のトッププレイヤーが提供する製品ポートフォリオに関する包括的な情報 製品開発/イノベーション。電気生理市場における今後の動向、研究開発活動、製品の上市に関する詳細な洞察 市場開拓。有利な新興国地域に関する包括的な情報 市場の多様化。新製品、成長地域、電気生理学市場の最近の動向に関する詳細な情報 競争力のある評価。市場セグメント、成長戦略、収益分析、主要な市場プレイヤーの製品に関する詳細な評価。 目次1 INTRODUCTION 311.1 OBJECTIVES OF THE STUDY 31 1.2 MARKET DEFINITION 32 1.2.1 INCLUSIONS AND EXCLUSIONS 32 1.3 MARKET SCOPE 33 1.3.1 MARKETS COVERED 33 1.3.2 YEARS CONSIDERED 34 1.4 CURRENCY USED 34 TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 34 1.5 KEY MARKET STAKEHOLDERS 35 1.6 SUMMARY OF CHANGES 35 2 RESEARCH METHODOLOGY 37 2.1 RESEARCH DATA 37 FIGURE 1 RESEARCH DESIGN 37 2.1.1 SECONDARY DATA 38 2.1.1.1 Key data from secondary sources 38 2.1.1.2 Indicative list of secondary sources 40 2.1.2 PRIMARY DATA 41 2.1.2.1 Breakdown of primaries 41 FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 41 2.2 MARKET ESTIMATION METHODOLOGY 42 FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 42 2.2.1 VENDOR REVENUE-BASED MARKET ESTIMATION 43 FIGURE 4 MARKET SIZE ESTIMATION: VENDOR REVENUE-BASED MARKET ESTIMATION 44 2.2.2 END USER-BASED MARKET ESTIMATION 44 FIGURE 5 MARKET SIZE ESTIMATION: END USER-BASED MARKET ESTIMATION 44 2.2.3 PRIMARY RESEARCH VALIDATION 45 2.3 DATA TRIANGULATION METHODOLOGY 45 2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 45 FIGURE 6 DATA TRIANGULATION METHODOLOGY 46 2.5 RESEARCH ASSUMPTIONS 47 2.6 RESEARCH LIMITATIONS 47 3 EXECUTIVE SUMMARY 48 FIGURE 7 ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2021 VS. 2027 (USD MILLION) 48 FIGURE 8 ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2021 VS. 2027 (USD MILLION) 49 FIGURE 9 ELECTROPHYSIOLOGY MARKET, BY END USER, 2021 VS. 2027 (USD MILLION) 50 FIGURE 10 ASIA PACIFIC MARKET TO HAVE HIGHEST CAGR DURING FORECAST PERIOD (2022-2027) 51 4 PREMIUM INSIGHTS 52 4.1 ELECTROPHYSIOLOGY MARKET OVERVIEW 52 FIGURE 11 TECHNOLOGICAL ADVANCEMENTS TO DRIVE GLOBAL ELECTROPHYSIOLOGY MARKET GROWTH 52 4.2 GEOGRAPHIC ANALYSIS: ELECTROPHYSIOLOGY MARKET, BY INDICATION AND REGION 53 FIGURE 12 ATRIAL FIBRILLATION SEGMENT DOMINATED ELECTROPHYSIOLOGY MARKET IN 2021 BY INDICATION 53 4.3 GEOGRAPHIC ANALYSIS: ELECTROPHYSIOLOGY MARKET, BY PRODUCT AND INDICATION 54 FIGURE 13 ELECTROPHYSIOLOGY LABORATORY DEVICES SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2021 IN PRODUCT SEGMENT 54 4.4 ELECTROPHYSIOLOGY MARKET SHARE, BY END USER, 2021 VS. 2027 55 FIGURE 14 HOSPITALS & CARDIAC CENTERS SEGMENT TO ACCOUNT FOR LARGEST MARKET SHARE DURING FORECAST PERIOD 55 FIGURE 15 BY END USER 2021 VS 2027 55 4.5 GEOGRAPHICAL SNAPSHOT OF ELECTROPHYSIOLOGY MARKET 56 FIGURE 16 CHINA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD (2022-2027) 56 5 MARKET OVERVIEW 57 5.1 INTRODUCTION 57 5.2 MARKET DYNAMICS 57 FIGURE 17 ELECTROPHYSIOLOGY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 57 5.2.1 DRIVERS 57 5.2.1.1 High rate of technological advancements 57 5.2.1.1.1 Increased use of non-invasive cardiac mapping 58 5.2.1.1.2 Increased use of improved intracardiac ablation systems 58 5.2.1.1.3 Increased use of MRI guided ablation procedures 59 5.2.1.1.4 Growing level of ultrasound guidance in the EP Lab 59 5.2.1.2 Rising number of new entrants in the market 59 TABLE 2 NEW ENTRANTS IN THE CARDIAC MAPPING SYSTEMS MARKET 60 5.2.1.3 Growing investments, funds, and grants for cardiac surgeries and electrophysiology 61 5.2.1.4 Increasing incidence of target diseases and procedures 61 5.2.2 RESTRAINTS 62 5.2.2.1 High cost of electrophysiology products and inadequate reimbursement process 62 5.2.2.2 Unfavorable healthcare reforms in the US 63 5.2.2.3 Cost-intensive requirement for clinical data for new product launches along with availability of alternative technologies 63 5.2.3 OPPORTUNITIES 64 5.2.3.1 Rising number of emerging markets 64 5.2.4 CHALLENGES 65 5.2.4.1 Increasing rate of reusing and reprocessing of devices 65 5.2.4.2 Lack of skilled and experienced electrophysiologists 65 5.3 REGULATORY LANDSCAPE 66 TABLE 3 INDICATIVE LIST OF REGULATORY AUTHORITIES 66 5.3.1 NORTH AMERICA 66 5.3.1.1 US 66 TABLE 4 CLASSIFICATION OF MEDICAL DEVICES BY US FDA 67 TABLE 5 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 67 5.3.1.2 Canada 68 TABLE 6 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 68 5.3.2 EUROPE 68 5.3.3 ASIA PACIFIC 69 5.3.3.1 India 69 5.3.3.2 China 70 TABLE 7 CHINA (NPMA): CLASSIFICATION OF MEDICAL DEVICES 70 5.3.3.3 Japan 71 TABLE 8 CLASSIFICATION OF MEDICAL DEVICES BY PMDA 71 5.4 COVID-19 IMPACT 72 5.5 REIMBURSEMENT SCENARIO 73 TABLE 9 MEDICAL REIMBURSEMENT CODES FOR 2022 (PHYSICIAN) 74 TABLE 10 MEDICAL REIMBURSEMENT CODES FOR 2022 (HOSPITAL OUTPATIENT) 76 TABLE 11 MEDICAL REIMBURSEMENT CODES FOR 2022 (HOSPITAL INPATIENT) 77 5.6 PATENT ANALYSIS 78 5.6.1 PATENTS GRANTED FOR ELECTROPHYSIOLOGY 78 FIGURE 18 NUMBER OF PATENTS ISSUED (2011 -2021) 78 5.6.2 JURISDICTION AND TOP APPLICANT ANALYSIS 79 TABLE 12 TOP 10 PATENT OWNERS FOR ELECTROPHYSIOLOGY (JANUARY 2011 TO DECEMBER 2021) 79 FIGURE 19 TOP 10 PATENTS OWNERS FOR ELECTROPHYSIOLOGY (JANUARY 2011 TO DECEMBER 2021) 79 FIGURE 20 TOP 10 PATENT APPLICANTS FOR ELECTROPHYSIOLOGY (JANUARY 2011 TO DECEMBER 2021) 80 FIGURE 21 PATENTS FOR ELECTROPHYSIOLOGY, BY JURISDICTION (JANUARY 2011 TO DECEMBER 2021) 80 5.7 VALUE CHAIN ANALYSIS 81 FIGURE 22 VALUE CHAIN OF ELECTROPHYSIOLOGY MARKET 81 5.8 PRICING TREND ANALYSIS 82 TABLE 13 AVERAGE PRICE OF ELECTROPHYSIOLOGY PRODUCTS, BY DEVICE NAME, 2020 (USD) 82 5.9 PORTER’S FIVE FORCES ANALYSIS 82 TABLE 14 ELECTROPHYSIOLOGY MARKET: PORTER’S FIVE FORCES ANALYSIS 82 5.9.1 THREAT OF NEW ENTRANTS 83 5.9.2 THREAT OF SUBSTITUTES 83 5.9.3 BARGAINING POWER OF SUPPLIERS 83 5.9.4 BARGAINING POWER OF BUYERS 83 5.9.5 INTENSITY OF COMPETITIVE RIVALRY 83 5.10 ECOSYSTEM LANDSCAPE 84 FIGURE 23 ELECTROPHYSIOLOGY MARKET: ECOSYSTEM LANDSCAPE 84 6 ELECTROPHYSIOLOGY MARKET, BY PRODUCT 85 6.1 INTRODUCTION 86 TABLE 15 ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2019–2027 (USD MILLION) 86 6.2 ELECTROPHYSIOLOGY LABORATORY DEVICES 86 TABLE 16 EP LABORATORY DEVICES MARKET, BY TYPE, 2019–2027 (USD MILLION) 87 TABLE 17 EP LABORATORY DEVICES MARKET, BY INDICATION, 2019–2027 (USD MILLION) 87 TABLE 18 EP LABORATORY DEVICES MARKET, BY END USER, 2019–2027 (USD MILLION) 88 TABLE 19 EP LABORATORY DEVICES MARKET, BY REGION, 2019–2027 (USD MILLION) 88 6.2.1 3D MAPPING SYSTEMS 88 6.2.1.1 Development of alternative technologies to hinder market growth 88 TABLE 20 3D MAPPING SYSTEMS MARKET, BY REGION, 2019–2027 (USD MILLION) 89 6.2.2 ELECTROPHYSIOLOGY RECORDING SYSTEMS 90 6.2.2.1 Increasing public-private funding to drive market growth 90 TABLE 21 ELECTROPHYSIOLOGY RECORDING SYSTEMS MARKET, BY REGION, 2019–2027 (USD MILLION) 90 6.2.3 RADIOFREQUENCY (RF) ABLATION SYSTEMS 91 6.2.3.1 Rising number of RF ablation procedures to drive market growth 91 TABLE 22 RF ABLATION SYSTEMS MARKET, BY REGION, 2019–2027 (USD MILLION) 91 6.2.4 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) ULTRASOUND IMAGING SYSTEMS 92 6.2.4.1 Advantages of ICE ultrasound imaging systems to drive market growth 92 TABLE 23 ICE ULTRASOUND IMAGING SYSTEMS MARKET, BY REGION, 2019–2027 (USD MILLION) 92 6.2.5 ELECTROPHYSIOLOGY X-RAY SYSTEMS 93 6.2.5.1 Magnetic navigation systems to hamper market growth 93 TABLE 24 ELECTROPHYSIOLOGY X-RAY SYSTEMS MARKET, BY REGION, 2019–2027 (USD MILLION) 93 6.2.6 ELECTROPHYSIOLOGY REMOTE MAGNETIC AND ROBOTIC NAVIGATION SYSTEMS 94 6.2.6.1 Favorable reimbursement scenario to drive market growth 94 TABLE 25 ELECTROPHYSIOLOGY REMOTE MAGNETIC AND ROBOTIC NAVIGATION SYSTEMS MARKET, BY REGION, 2019–2027 (USD MILLION) 95 6.3 ELECTROPHYSIOLOGY ABLATION CATHETERS 95 TABLE 26 EP ABLATION CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION) 95 TABLE 27 EP ABLATION CATHETERS MARKET, BY INDICATION, 2019–2027 (USD MILLION) 96 TABLE 28 EP ABLATION CATHETERS MARKET, BY END USER, 2019–2027 (USD MILLION) 96 TABLE 29 EP ABLATION CATHETERS MARKET, BY REGION, 2019–2027 (USD MILLION) 97 6.3.1 CRYOABLATION ELECTROPHYSIOLOGY CATHETERS 97 6.3.1.1 Significant therapeutic advantages to drive market growth 97 TABLE 30 CRYOABLATION EP CATHETERS MARKET, BY REGION, 2019–2027 (USD MILLION) 98 6.3.2 RADIOFREQUENCY (RF) ABLATION CATHETERS 98 6.3.2.1 Technological advancements in radiofrequency ablation catheters to drive the market 98 TABLE 31 RF ABLATION CATHETERS MARKET, BY REGION, 2019–2027 (USD MILLION) 99 6.3.3 MICROWAVE ABLATION (MWA) SYSTEMS 99 6.3.3.1 Advantages of Microwave Ablation Systems over RF Ablation Catheters to drive market growth 99 TABLE 32 MWA SYSTEMS MARKET, BY REGION, 2019–2027 (USD MILLION) 101 6.3.4 LASER ABLATION SYSTEMS 101 6.3.4.1 Technologically advanced products to drive market growth 101 TABLE 33 LASER ABLATION SYSTEMS MARKET, BY REGION, 2019–2027 (USD MILLION) 102 6.4 ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS 102 TABLE 34 EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION) 102 TABLE 35 EP DIAGNOSTIC CATHETERS MARKET, BY INDICATION, 2019–2027 (USD MILLION) 103 TABLE 36 EP DIAGNOSTIC CATHETERS MARKET, BY END USER, 2019–2027 (USD MILLION) 103 TABLE 37 EP DIAGNOSTIC CATHETERS MARKET, BY REGION, 2019–2027 (USD MILLION) 104 6.4.1 CONVENTIONAL ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS 104 6.4.1.1 Increasing demand in emerging markets to support market growth 104 TABLE 38 CONVENTIONAL EP DIAGNOSTIC CATHETERS MARKET, BY REGION, 2019–2027 (USD MILLION) 105 6.4.2 ADVANCED ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS 105 6.4.2.1 Advantages of Advanced Electrophysiology Diagnostic Catheters over conventional EP diagnostic catheters to drive market growth 105 TABLE 39 ADVANCED EP DIAGNOSTIC CATHETERS MARKET, BY REGION, 2019–2027 (USD MILLION) 106 6.4.3 ULTRASOUND ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS 106 6.4.3.1 Increased demand due to rising use of ICE ultrasound imaging systems to drive market growth 106 TABLE 40 ULTRASOUND EP DIAGNOSTIC CATHETERS MARKET, BY REGION, 2019–2027 (USD MILLION) 107 6.5 ACCESS DEVICES 107 6.5.1 LAUNCH OF TECHNOLOGICALLY ADVANCED PRODUCTS TO DRIVE MARKET GROWTH 107 TABLE 41 ACCESS DEVICES MARKET, BY INDICATION, 2019–2027 (USD MILLION) 108 TABLE 42 ACCESS DEVICES MARKET, BY END USER, 2019–2027 (USD MILLION) 108 TABLE 43 ACCESS DEVICES MARKET, BY REGION, 2019–2027 (USD MILLION) 109 6.6 OTHER PRODUCTS 109 TABLE 44 OTHER PRODUCTS MARKET, BY INDICATION, 2019–2027 (USD MILLION) 109 TABLE 45 OTHER PRODUCTS MARKET, BY END USER, 2019–2027 (USD MILLION) 110 TABLE 46 OTHER PRODUCTS MARKET, BY REGION, 2019–2027 (USD MILLION) 110 7 ELECTROPHYSIOLOGY MARKET, BY INDICATION TYPE 111 7.1 INTRODUCTION 112 TABLE 47 ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2019–2027 (USD MILLION) 112 7.2 ATRIAL FIBRILLATION 112 7.2.1 GROWING INITIATIVES TO SHOWCASE ADVANTAGES OF CATHETER ABLATION OVER ANTIARRHYTHMIC DRUGS TO DRIVE MARKET GROWTH 112 TABLE 48 ELECTROPHYSIOLOGY MARKET FOR ATRIAL FIBRILLATION, BY REGION, 2019–2027 (USD MILLION) 113 7.3 ATRIAL FLUTTER 114 7.3.1 HIGH SUCCESS RATE OF RADIOFREQUENCY CATHETER ABLATION FOR TREATMENT OF ATRIAL FLUTTER TO DRIVE MARKET GROWTH 114 TABLE 49 ELECTROPHYSIOLOGY MARKET FOR ATRIAL FLUTTER, BY REGION, 2019–2027 (USD MILLION) 114 7.4 ATRIOVENTRICULAR NODAL REENTRY TACHYCARDIA (AVNRT) 115 7.4.1 INCREASING VALIDATION OF EFFICACY OF ELECTROPHYSIOLOGY DEVICES FOR AVNRT TO DRIVE MARKET GROWTH 115 TABLE 50 ELECTROPHYSIOLOGY MARKET FOR ATRIOVENTRICULAR NODAL REENTRY TACHYCARDIA, BY REGION, 2019–2027 (USD MILLION) 115 7.5 WOLFF-PARKINSON-WHITE SYNDROME (WPW) 116 7.5.1 PREFERENCE FOR RADIOFREQUENCY ABLATION OVER SURGERY TO TREAT WOLFF-PARKINSON-WHITE SYNDROME TO DRIVE MARKET GROWTH 116 TABLE 51 ELECTROPHYSIOLOGY MARKET FOR WOLFF-PARKINSON-WHITE SYNDROME, BY REGION, 2019–2027 (USD MILLION) 116 7.6 OTHER INDICATIONS 117 TABLE 52 ELECTROPHYSIOLOGY MARKET FOR OTHER INDICATIONS, BY REGION, 2019–2027 (USD MILLION) 117 8 ELECTROPHYSIOLOGY MARKET, BY END USER 118 8.1 INTRODUCTION 119 TABLE 53 ELECTROPHYSIOLOGY MARKET, BY END USER, 2019–2027 (USD MILLION) 119 8.2 HOSPITALS & CARDIAC CENTERS 119 8.2.1 HOSPITAL & CARDIAC CENTERS TO DOMINATE END USER SEGMENT 119 TABLE 54 ELECTROPHYSIOLOGY MARKET FOR HOSPITALS & CARDIAC CENTERS, BY REGION, 2019–2027 (USD MILLION) 120 8.3 AMBULATORY SURGERY CENTERS 120 8.3.1 INCREASING NUMBER OF AMBULATORY SURGICAL CENTERS IN THE US TO DRIVE ADOPTION OF ELECTROPHYSIOLOGY DEVICES 120 TABLE 55 ELECTROPHYSIOLOGY MARKET FOR AMBULATORY SURGERY CENTERS, BY REGION, 2019–2027 (USD MILLION) 121 9 ELECTROPHYSIOLOGY MARKET, BY REGION 122 9.1 INTRODUCTION 123 FIGURE 24 GEOGRAPHIC SNAPSHOT OF ELECTROPHYSIOLOGY MARKET 123 TABLE 56 ELECTROPHYSIOLOGY MARKET, BY REGION, 2019–2027 (USD MILLION) 124 9.2 NORTH AMERICA 125 FIGURE 25 NORTH AMERICA: ELECTROPHYSIOLOGY MARKET SNAPSHOT 125 TABLE 57 NORTH AMERICA: ELECTROPHYSIOLOGY MARKET, BY COUNTRY, 2019–2027 (USD MILLION) 126 TABLE 58 NORTH AMERICA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2019–2027 (USD MILLION) 126 TABLE 59 NORTH AMERICA: EP LABORATORY DEVICES MARKET, BY TYPE, 2019–2027 (USD MILLION) 127 TABLE 60 NORTH AMERICA: EP ABLATION CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION) 127 TABLE 61 NORTH AMERICA: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION) 128 TABLE 62 NORTH AMERICA: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2019–2027 (USD MILLION) 128 TABLE 63 NORTH AMERICA: ELECTROPHYSIOLOGY MARKET, BY END USER, 2019–2027 (USD MILLION) 129 9.2.1 US 129 9.2.1.1 Technological advancements to drive market growth 129 TABLE 64 CLINICAL TRIALS RELATED TO ELECTROPHYSIOLOGY DEVICES 130 TABLE 65 US: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2019–2027 (USD MILLION) 131 TABLE 66 US: EP LABORATORY DEVICES MARKET, BY TYPE, 2019–2027 (USD MILLION) 131 TABLE 67 US: EP ABLATION CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION) 132 TABLE 68 US: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION) 132 9.2.2 CANADA 133 9.2.2.1 Growing government funding for research to support market growth 133 TABLE 69 RESEARCH GRANTS TOWARDS RESEARCH IN CARDIOLOGY 134 TABLE 70 CANADA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2019–2027 (USD MILLION) 135 TABLE 71 CANADA: EP LABORATORY DEVICES MARKET, BY TYPE, 2019–2027 (USD MILLION) 135 TABLE 72 CANADA: EP ABLATION CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION) 136 TABLE 73 CANADA: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION) 136 9.3 EUROPE 137 TABLE 74 EUROPE: ELECTROPHYSIOLOGY MARKET, BY COUNTRY, 2019–2027 (USD MILLION) 137 TABLE 75 EUROPE: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2019–2027 (USD MILLION) 138 TABLE 76 EUROPE: EP LABORATORY DEVICES MARKET, BY TYPE, 2019–2027 (USD MILLION) 138 TABLE 77 EUROPE: EP ABLATION CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION) 139 TABLE 78 EUROPE: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION) 139 TABLE 79 EUROPE: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2019–2027 (USD MILLION) 140 TABLE 80 EUROPE: ELECTROPHYSIOLOGY MARKET, BY END USER, 2019–2027 (USD MILLION) 140 9.3.1 GERMANY 141 9.3.1.1 Rising healthcare expenditure and growing use of electrophysiology devices to drive market growth 141 TABLE 81 GERMANY: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2019–2027 (USD MILLION) 141 TABLE 82 GERMANY: EP LABORATORY DEVICES MARKET, BY TYPE, 2019–2027 (USD MILLION) 142 TABLE 83 GERMANY: EP ABLATION CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION) 142 TABLE 84 GERMANY: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION) 143 9.3.2 UK 143 9.3.2.1 Growing geriatric population to drive market growth 143 TABLE 85 UK: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2019–2027 (USD MILLION) 144 TABLE 86 UK: EP LABORATORY DEVICES MARKET, BY TYPE, 2019–2027 (USD MILLION) 144 TABLE 87 UK: EP ABLATION CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION) 145 TABLE 88 UK: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION) 145 9.3.3 FRANCE 146 9.3.3.1 Increasing incidence of heart failure to support market growth 146 TABLE 89 FRANCE: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2019–2027 (USD MILLION) 146 TABLE 90 FRANCE: EP LABORATORY DEVICES MARKET, BY TYPE, 2019–2027 (USD MILLION) 147 TABLE 91 FRANCE: EP ABLATION CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION) 147 TABLE 92 FRANCE: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION) 148 9.3.4 ITALY 148 9.3.4.1 Rising incidence of CVDs to drive electrophysiology devices adoption 148 TABLE 93 ITALY: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2019–2027 (USD MILLION) 149 TABLE 94 ITALY: EP LABORATORY DEVICES MARKET, BY TYPE, 2019–2027 (USD MILLION) 149 TABLE 95 ITALY: EP ABLATION CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION) 150 TABLE 96 ITALY: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION) 150 9.3.5 SPAIN 151 9.3.5.1 Growing number of cardiac ablation procedures to drive market growth 151 TABLE 97 SPAIN: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2019–2027 (USD MILLION) 151 TABLE 98 SPAIN: EP LABORATORY DEVICES MARKET, BY TYPE, 2019–2027 (USD MILLION) 152 TABLE 99 SPAIN: EP ABLATION CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION) 152 TABLE 100 SPAIN: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION) 153 9.3.6 REST OF EUROPE 153 TABLE 101 CARDIAC AF ABLATION PROCEDURES, BY COUNTRY, 2015 VS. 2016 154 TABLE 102 ROE: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2019–2027 (USD MILLION) 154 TABLE 103 ROE: EP LABORATORY DEVICES MARKET, BY TYPE, 2019–2027 (USD MILLION) 155 TABLE 104 ROE: EP ABLATION CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION) 155 TABLE 105 ROE: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION) 156 9.4 ASIA PACIFIC 156 FIGURE 26 ASIA PACIFIC: ELECTROPHYSIOLOGY MARKET SNAPSHOT 157 TABLE 106 ASIA PACIFIC: ELECTROPHYSIOLOGY MARKET, BY COUNTRY, 2019–2027 (USD MILLION) 158 TABLE 107 ASIA PACIFIC: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2019–2027 (USD MILLION) 158 TABLE 108 ASIA PACIFIC: EP LABORATORY DEVICES MARKET, BY TYPE, 2019–2027 (USD MILLION) 159 TABLE 109 ASIA PACIFIC: EP ABLATION CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION) 159 TABLE 110 ASIA PACIFIC: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION) 160 TABLE 111 ASIA PACIFIC: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2019–2027 (USD MILLION) 160 TABLE 112 ASIA PACIFIC: ELECTROPHYSIOLOGY MARKET, BY END USER, 2019–2027 (USD MILLION) 161 9.4.1 JAPAN 161 9.4.1.1 Favorable reimbursement scenario to support market growth 161 TABLE 113 JAPAN: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2019–2027 (USD MILLION) 162 TABLE 114 JAPAN: EP LABORATORY DEVICES MARKET, BY TYPE, 2019–2027 (USD MILLION) 162 TABLE 115 JAPAN: EP ABLATION CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION) 163 TABLE 116 JAPAN: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION) 163 9.4.2 CHINA 164 9.4.2.1 Growing geriatric population to drive market growth 164 TABLE 117 CHINA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2019–2027 (USD MILLION) 164 TABLE 118 CHINA: EP LABORATORY DEVICES MARKET, BY TYPE, 2019–2027 (USD MILLION) 165 TABLE 119 CHINA: EP ABLATION CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION) 165 TABLE 120 CHINA: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION) 166 9.4.3 INDIA 166 9.4.3.1 Increasing healthcare initiatives by government to drive market growth 166 TABLE 121 INDIA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2019–2027 (USD MILLION) 167 TABLE 122 INDIA: EP LABORATORY DEVICES MARKET, BY TYPE, 2019–2027 (USD MILLION) 167 TABLE 123 INDIA: EP ABLATION CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION) 168 TABLE 124 INDIA: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION) 168 9.4.4 AUSTRALIA 169 9.4.4.1 Increasing target disease burden to support market growth 169 TABLE 125 AUSTRALIA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2019–2027 (USD MILLION) 169 TABLE 126 AUSTRALIA: EP LABORATORY DEVICES MARKET, BY TYPE, 2019–2027 (USD MILLION) 170 TABLE 127 AUSTRALIA: EP ABLATION CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION) 170 TABLE 128 AUSTRALIA: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION) 171 9.4.5 SOUTH KOREA 171 9.4.5.1 Supportive government initiatives to drive market growth 171 TABLE 129 SOUTH KOREA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2019–2027 (USD MILLION) 172 TABLE 130 SOUTH KOREA: EP LABORATORY DEVICES MARKET, BY TYPE, 2019–2027 (USD MILLION) 172 TABLE 131 SOUTH KOREA: EP ABLATION CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION) 173 TABLE 132 SOUTH KOREA: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION) 173 9.4.6 REST OF ASIA PACIFIC 173 TABLE 133 ROAPAC: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2019–2027 (USD MILLION) 174 TABLE 134 ROAPAC: EP LABORATORY DEVICES MARKET, BY TYPE, 2019–2027 (USD MILLION) 175 TABLE 135 ROAPAC: EP ABLATION CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION) 175 TABLE 136 ROAPAC: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION) 176 9.5 LATIN AMERICA 176 TABLE 137 LATAM: ELECTROPHYSIOLOGY MARKET, BY COUNTRY, 2019–2027 (USD MILLION) 177 TABLE 138 LATAM: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2019–2027 (USD MILLION) 177 TABLE 139 LATAM: EP LABORATORY DEVICES MARKET, BY TYPE, 2019–2027 (USD MILLION) 178 TABLE 140 LATAM: EP ABLATION CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION) 178 TABLE 141 LATAM: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION) 179 TABLE 142 LATAM: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2019–2027 (USD MILLION) 179 TABLE 143 LATAM: ELECTROPHYSIOLOGY MARKET, BY END USER, 2019–2027 (USD MILLION) 180 9.5.1 BRAZIL 180 9.5.1.1 Modernization of healthcare facilities to drive market growth 180 TABLE 144 BRAZIL: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2019–2027 (USD MILLION) 181 TABLE 145 BRAZIL: EP LABORATORY DEVICES MARKET, BY TYPE, 2019–2027 (USD MILLION) 181 TABLE 146 BRAZIL: EP ABLATION CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION) 182 TABLE 147 BRAZIL: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION) 182 9.5.2 MEXICO 183 9.5.2.1 Favorable investment scenario for medical device manufacturers to drive market growth 183 TABLE 148 MEXICO: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2019–2027 (USD MILLION) 183 TABLE 149 MEXICO: EP LABORATORY DEVICES MARKET, BY TYPE, 2019–2027 (USD MILLION) 184 TABLE 150 MEXICO: EP ABLATION CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION) 184 TABLE 151 MEXICO: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION) 185 9.5.3 REST OF LATIN AMERICA 185 TABLE 152 ROLA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2019–2027 (USD MILLION) 185 TABLE 153 ROLA: EP LABORATORY DEVICES MARKET, BY TYPE, 2019–2027 (USD MILLION) 186 TABLE 154 ROLA: EP ABLATION CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION) 186 TABLE 155 ROLA: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION) 187 9.6 MIDDLE EAST & AFRICA 187 TABLE 156 MEA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2019–2027 (USD MILLION) 188 TABLE 157 MEA: EP LABORATORY DEVICES MARKET, BY TYPE, 2019–2027 (USD MILLION) 188 TABLE 158 MEA: EP ABLATION CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION) 189 TABLE 159 MEA: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION) 189 TABLE 160 MEA: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2019–2027 (USD MILLION) 190 TABLE 161 MEA: ELECTROPHYSIOLOGY MARKET, BY END USER, 2019–2027 (USD MILLION) 190 10 COMPETITIVE LANDSCAPE 191 10.1 INTRODUCTION 191 FIGURE 27 KEY DEVELOPMENTS BY LEADING PLAYERS IN ELECTROPHYSIOLOGY MARKET, 2018–2021 191 10.2 REVENUE SHARE ANALYSIS 192 FIGURE 28 REVENUE SHARE ANALYSIS OF TOP PLAYERS IN ELECTROPHYSIOLOGY MARKET 192 10.3 MARKET SHARE ANALYSIS 193 FIGURE 29 ELECTROPHYSIOLOGY MARKET SHARE, BY KEY PLAYER, 2020 193 TABLE 162 ELECTROPHYSIOLOGY MARKET: DEGREE OF COMPETITION 193 10.4 COMPETITIVE LEADERSHIP MAPPING: COMPANY EVALUATION QUADRANT (2020) 195 10.4.1 STARS 195 10.4.2 EMERGING LEADERS 195 10.4.3 PERVASIVE PLAYERS 195 10.4.4 PARTICIPANTS 195 FIGURE 30 ELECTROPHYSIOLOGY MARKET: COMPETITIVE LEADERSHIP MAPPING (2020) 196 10.5 COMPETITIVE LEADERSHIP MAPPING: START-UP/SME EVALUATION QUADRANT (AS OF 2020) 197 10.5.1 PROGRESSIVE COMPANIES 197 10.5.2 RESPONSIVE COMPANIES 197 10.5.3 DYNAMIC COMPANIES 197 10.5.4 STARTING BLOCKS 197 FIGURE 31 ELECTROPHYSIOLOGY MARKET: COMPETITIVE LEADERSHIP MAPPING (SMES/START-UPS) (2020) 198 10.6 COMPETITIVE BENCHMARKING 199 TABLE 163 PRODUCT FOOTPRINT ANALYSIS OF TOP PLAYERS IN ELECTROPHYSIOLOGY MARKET 199 TABLE 164 COMPANY FOOTPRINT ANALYSIS IN ELECTROPHYSIOLOGY MARKET 200 10.7 COMPETITIVE SCENARIO (2018–2021) 201 10.7.1 PRODUCT LAUNCHES 201 10.7.2 APPROVALS 202 10.7.3 DEALS 204 11 COMPANY PROFILES 208 11.1 KEY PLAYERS 208 (Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))* 11.1.1 ABBOTT 208 TABLE 165 ABBOTT: BUSINESS OVERVIEW 208 FIGURE 32 ABBOTT: COMPANY SNAPSHOT (2020) 209 11.1.2 MEDTRONIC 214 TABLE 166 MEDTRONIC: BUSINESS OVERVIEW 214 FIGURE 33 MEDTRONIC: COMPANY SNAPSHOT (2021) 215 11.1.3 BOSTON SCIENTIFIC CORPORATION 220 TABLE 167 BOSTON SCIENTIFIC CORPORATION: BUSINESS OVERVIEW 220 FIGURE 34 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2020) 221 11.1.4 KONINKLIJKE PHILIPS N.V. 227 TABLE 168 KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW 227 FIGURE 35 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2020) 228 11.1.5 GE HEALTHCARE 231 TABLE 169 GE HEALTHCARE: BUSINESS OVERVIEW 231 FIGURE 36 GE HEALTHCARE: COMPANY SNAPSHOT (2020) 232 11.1.6 SIEMENS HEALTHINEERS 234 TABLE 170 SIEMENS HEALTHINEERS: BUSINESS OVERVIEW 234 FIGURE 37 SIEMENS HEALTHINEERS: COMPANY SNAPSHOT (2020) 235 11.1.7 STEREOTAXIS, INC. 237 TABLE 171 STEREOTAXIS, INC.: BUSINESS OVERVIEW 237 FIGURE 38 STEREOTAXIS: COMPANY SNAPSHOT (2020) 238 11.1.8 MERIT MEDICAL SYSTEMS 241 TABLE 172 MERIT MEDICAL SYSTEMS: BUSINESS OVERVIEW 241 FIGURE 39 MERIT MEDICAL SYSTEMS: COMPANY SNAPSHOT (2020) 242 11.1.9 ATRICURE INC. 243 TABLE 173 ATRICURE, INC.: BUSINESS OVERVIEW 243 FIGURE 40 ATRICURE, INC.: COMPANY SNAPSHOT (2020) 244 11.1.10 APN HEALTH, LLC 246 TABLE 174 APN HEALTH, LLC: BUSINESS OVERVIEW 246 11.1.11 OSYPKA MEDICAL 247 TABLE 175 OSYPKA MEDICAL: BUSINESS OVERVIEW 247 11.1.12 JAPAN LIFELINE CO., LTD. 249 TABLE 176 JAPAN LIFELINE CO., LTD.: BUSINESS OVERVIEW 249 FIGURE 41 JAPAN LIFELINE CO., LTD.: COMPANY SNAPSHOT (2020) 249 11.1.13 JOHNSON & JOHNSON 251 TABLE 177 JOHNSON & JOHNSON: BUSINESS OVERVIEW 251 FIGURE 42 JOHNSON & JOHNSON: COMPANY SNAPSHOT (2020) 252 11.1.14 BIOTRONIK 258 TABLE 178 BIOTRONIK: BUSINESS OVERVIEW 258 11.1.15 MICROPORT SCIENTIFIC CORPORATION 262 TABLE 179 MICROPORT SCIENTIFIC CORPORATION: BUSINESS OVERVIEW 262 FIGURE 43 MICROPORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2020) 263 11.1.16 ACUTUS MEDICAL, INC. 265 TABLE 180 ACUTUS MEDICAL, INC.: BUSINESS OVERVIEW 265 FIGURE 44 ACUTUS MEDICAL INC.: COMPANY SNAPSHOT (2020) 266 11.2 OTHER PLAYERS 269 11.2.1 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD. 269 11.2.2 CATHRX LTD. 270 11.2.3 COOK MEDICAL 271 11.2.4 CATHVISION APS 272 11.2.5 TZ MEDICAL 273 11.2.6 TELEFLEX INCORPORATED 274 11.2.7 IMRICOR 275 11.2.8 CARDIOFOCUS 276 11.2.9 SCHWARZER CARDIOTEK GMBH 277 11.2.10 KARDIUM 278 11.2.11 EP SOLUTIONS SA 279 11.2.12 BIOSIG TECHNOLOGIES, INC. (BSGM) 280 11.2.13 COREMAP 281 11.2.14 EPMAP SYSTEM GMBH 282 *Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies. 12 APPENDIX 283 12.1 DISCUSSION GUIDE 283 12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 288 12.3 AVAILABLE CUSTOMIZATIONS 290 12.4 RELATED REPORTS 290 12.5 AUTHOR DETAILS 291
SummaryThe global electrophysiology market is projected to reach USD 11.6 billion by 2027 from USD 6.8 billion in 2021, at a CAGR of 9.4% during the forecast period of 2022 to 2027. Table of Contents1 INTRODUCTION 311.1 OBJECTIVES OF THE STUDY 31 1.2 MARKET DEFINITION 32 1.2.1 INCLUSIONS AND EXCLUSIONS 32 1.3 MARKET SCOPE 33 1.3.1 MARKETS COVERED 33 1.3.2 YEARS CONSIDERED 34 1.4 CURRENCY USED 34 TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 34 1.5 KEY MARKET STAKEHOLDERS 35 1.6 SUMMARY OF CHANGES 35 2 RESEARCH METHODOLOGY 37 2.1 RESEARCH DATA 37 FIGURE 1 RESEARCH DESIGN 37 2.1.1 SECONDARY DATA 38 2.1.1.1 Key data from secondary sources 38 2.1.1.2 Indicative list of secondary sources 40 2.1.2 PRIMARY DATA 41 2.1.2.1 Breakdown of primaries 41 FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 41 2.2 MARKET ESTIMATION METHODOLOGY 42 FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 42 2.2.1 VENDOR REVENUE-BASED MARKET ESTIMATION 43 FIGURE 4 MARKET SIZE ESTIMATION: VENDOR REVENUE-BASED MARKET ESTIMATION 44 2.2.2 END USER-BASED MARKET ESTIMATION 44 FIGURE 5 MARKET SIZE ESTIMATION: END USER-BASED MARKET ESTIMATION 44 2.2.3 PRIMARY RESEARCH VALIDATION 45 2.3 DATA TRIANGULATION METHODOLOGY 45 2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 45 FIGURE 6 DATA TRIANGULATION METHODOLOGY 46 2.5 RESEARCH ASSUMPTIONS 47 2.6 RESEARCH LIMITATIONS 47 3 EXECUTIVE SUMMARY 48 FIGURE 7 ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2021 VS. 2027 (USD MILLION) 48 FIGURE 8 ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2021 VS. 2027 (USD MILLION) 49 FIGURE 9 ELECTROPHYSIOLOGY MARKET, BY END USER, 2021 VS. 2027 (USD MILLION) 50 FIGURE 10 ASIA PACIFIC MARKET TO HAVE HIGHEST CAGR DURING FORECAST PERIOD (2022-2027) 51 4 PREMIUM INSIGHTS 52 4.1 ELECTROPHYSIOLOGY MARKET OVERVIEW 52 FIGURE 11 TECHNOLOGICAL ADVANCEMENTS TO DRIVE GLOBAL ELECTROPHYSIOLOGY MARKET GROWTH 52 4.2 GEOGRAPHIC ANALYSIS: ELECTROPHYSIOLOGY MARKET, BY INDICATION AND REGION 53 FIGURE 12 ATRIAL FIBRILLATION SEGMENT DOMINATED ELECTROPHYSIOLOGY MARKET IN 2021 BY INDICATION 53 4.3 GEOGRAPHIC ANALYSIS: ELECTROPHYSIOLOGY MARKET, BY PRODUCT AND INDICATION 54 FIGURE 13 ELECTROPHYSIOLOGY LABORATORY DEVICES SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2021 IN PRODUCT SEGMENT 54 4.4 ELECTROPHYSIOLOGY MARKET SHARE, BY END USER, 2021 VS. 2027 55 FIGURE 14 HOSPITALS & CARDIAC CENTERS SEGMENT TO ACCOUNT FOR LARGEST MARKET SHARE DURING FORECAST PERIOD 55 FIGURE 15 BY END USER 2021 VS 2027 55 4.5 GEOGRAPHICAL SNAPSHOT OF ELECTROPHYSIOLOGY MARKET 56 FIGURE 16 CHINA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD (2022-2027) 56 5 MARKET OVERVIEW 57 5.1 INTRODUCTION 57 5.2 MARKET DYNAMICS 57 FIGURE 17 ELECTROPHYSIOLOGY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 57 5.2.1 DRIVERS 57 5.2.1.1 High rate of technological advancements 57 5.2.1.1.1 Increased use of non-invasive cardiac mapping 58 5.2.1.1.2 Increased use of improved intracardiac ablation systems 58 5.2.1.1.3 Increased use of MRI guided ablation procedures 59 5.2.1.1.4 Growing level of ultrasound guidance in the EP Lab 59 5.2.1.2 Rising number of new entrants in the market 59 TABLE 2 NEW ENTRANTS IN THE CARDIAC MAPPING SYSTEMS MARKET 60 5.2.1.3 Growing investments, funds, and grants for cardiac surgeries and electrophysiology 61 5.2.1.4 Increasing incidence of target diseases and procedures 61 5.2.2 RESTRAINTS 62 5.2.2.1 High cost of electrophysiology products and inadequate reimbursement process 62 5.2.2.2 Unfavorable healthcare reforms in the US 63 5.2.2.3 Cost-intensive requirement for clinical data for new product launches along with availability of alternative technologies 63 5.2.3 OPPORTUNITIES 64 5.2.3.1 Rising number of emerging markets 64 5.2.4 CHALLENGES 65 5.2.4.1 Increasing rate of reusing and reprocessing of devices 65 5.2.4.2 Lack of skilled and experienced electrophysiologists 65 5.3 REGULATORY LANDSCAPE 66 TABLE 3 INDICATIVE LIST OF REGULATORY AUTHORITIES 66 5.3.1 NORTH AMERICA 66 5.3.1.1 US 66 TABLE 4 CLASSIFICATION OF MEDICAL DEVICES BY US FDA 67 TABLE 5 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 67 5.3.1.2 Canada 68 TABLE 6 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 68 5.3.2 EUROPE 68 5.3.3 ASIA PACIFIC 69 5.3.3.1 India 69 5.3.3.2 China 70 TABLE 7 CHINA (NPMA): CLASSIFICATION OF MEDICAL DEVICES 70 5.3.3.3 Japan 71 TABLE 8 CLASSIFICATION OF MEDICAL DEVICES BY PMDA 71 5.4 COVID-19 IMPACT 72 5.5 REIMBURSEMENT SCENARIO 73 TABLE 9 MEDICAL REIMBURSEMENT CODES FOR 2022 (PHYSICIAN) 74 TABLE 10 MEDICAL REIMBURSEMENT CODES FOR 2022 (HOSPITAL OUTPATIENT) 76 TABLE 11 MEDICAL REIMBURSEMENT CODES FOR 2022 (HOSPITAL INPATIENT) 77 5.6 PATENT ANALYSIS 78 5.6.1 PATENTS GRANTED FOR ELECTROPHYSIOLOGY 78 FIGURE 18 NUMBER OF PATENTS ISSUED (2011 -2021) 78 5.6.2 JURISDICTION AND TOP APPLICANT ANALYSIS 79 TABLE 12 TOP 10 PATENT OWNERS FOR ELECTROPHYSIOLOGY (JANUARY 2011 TO DECEMBER 2021) 79 FIGURE 19 TOP 10 PATENTS OWNERS FOR ELECTROPHYSIOLOGY (JANUARY 2011 TO DECEMBER 2021) 79 FIGURE 20 TOP 10 PATENT APPLICANTS FOR ELECTROPHYSIOLOGY (JANUARY 2011 TO DECEMBER 2021) 80 FIGURE 21 PATENTS FOR ELECTROPHYSIOLOGY, BY JURISDICTION (JANUARY 2011 TO DECEMBER 2021) 80 5.7 VALUE CHAIN ANALYSIS 81 FIGURE 22 VALUE CHAIN OF ELECTROPHYSIOLOGY MARKET 81 5.8 PRICING TREND ANALYSIS 82 TABLE 13 AVERAGE PRICE OF ELECTROPHYSIOLOGY PRODUCTS, BY DEVICE NAME, 2020 (USD) 82 5.9 PORTER’S FIVE FORCES ANALYSIS 82 TABLE 14 ELECTROPHYSIOLOGY MARKET: PORTER’S FIVE FORCES ANALYSIS 82 5.9.1 THREAT OF NEW ENTRANTS 83 5.9.2 THREAT OF SUBSTITUTES 83 5.9.3 BARGAINING POWER OF SUPPLIERS 83 5.9.4 BARGAINING POWER OF BUYERS 83 5.9.5 INTENSITY OF COMPETITIVE RIVALRY 83 5.10 ECOSYSTEM LANDSCAPE 84 FIGURE 23 ELECTROPHYSIOLOGY MARKET: ECOSYSTEM LANDSCAPE 84 6 ELECTROPHYSIOLOGY MARKET, BY PRODUCT 85 6.1 INTRODUCTION 86 TABLE 15 ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2019–2027 (USD MILLION) 86 6.2 ELECTROPHYSIOLOGY LABORATORY DEVICES 86 TABLE 16 EP LABORATORY DEVICES MARKET, BY TYPE, 2019–2027 (USD MILLION) 87 TABLE 17 EP LABORATORY DEVICES MARKET, BY INDICATION, 2019–2027 (USD MILLION) 87 TABLE 18 EP LABORATORY DEVICES MARKET, BY END USER, 2019–2027 (USD MILLION) 88 TABLE 19 EP LABORATORY DEVICES MARKET, BY REGION, 2019–2027 (USD MILLION) 88 6.2.1 3D MAPPING SYSTEMS 88 6.2.1.1 Development of alternative technologies to hinder market growth 88 TABLE 20 3D MAPPING SYSTEMS MARKET, BY REGION, 2019–2027 (USD MILLION) 89 6.2.2 ELECTROPHYSIOLOGY RECORDING SYSTEMS 90 6.2.2.1 Increasing public-private funding to drive market growth 90 TABLE 21 ELECTROPHYSIOLOGY RECORDING SYSTEMS MARKET, BY REGION, 2019–2027 (USD MILLION) 90 6.2.3 RADIOFREQUENCY (RF) ABLATION SYSTEMS 91 6.2.3.1 Rising number of RF ablation procedures to drive market growth 91 TABLE 22 RF ABLATION SYSTEMS MARKET, BY REGION, 2019–2027 (USD MILLION) 91 6.2.4 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) ULTRASOUND IMAGING SYSTEMS 92 6.2.4.1 Advantages of ICE ultrasound imaging systems to drive market growth 92 TABLE 23 ICE ULTRASOUND IMAGING SYSTEMS MARKET, BY REGION, 2019–2027 (USD MILLION) 92 6.2.5 ELECTROPHYSIOLOGY X-RAY SYSTEMS 93 6.2.5.1 Magnetic navigation systems to hamper market growth 93 TABLE 24 ELECTROPHYSIOLOGY X-RAY SYSTEMS MARKET, BY REGION, 2019–2027 (USD MILLION) 93 6.2.6 ELECTROPHYSIOLOGY REMOTE MAGNETIC AND ROBOTIC NAVIGATION SYSTEMS 94 6.2.6.1 Favorable reimbursement scenario to drive market growth 94 TABLE 25 ELECTROPHYSIOLOGY REMOTE MAGNETIC AND ROBOTIC NAVIGATION SYSTEMS MARKET, BY REGION, 2019–2027 (USD MILLION) 95 6.3 ELECTROPHYSIOLOGY ABLATION CATHETERS 95 TABLE 26 EP ABLATION CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION) 95 TABLE 27 EP ABLATION CATHETERS MARKET, BY INDICATION, 2019–2027 (USD MILLION) 96 TABLE 28 EP ABLATION CATHETERS MARKET, BY END USER, 2019–2027 (USD MILLION) 96 TABLE 29 EP ABLATION CATHETERS MARKET, BY REGION, 2019–2027 (USD MILLION) 97 6.3.1 CRYOABLATION ELECTROPHYSIOLOGY CATHETERS 97 6.3.1.1 Significant therapeutic advantages to drive market growth 97 TABLE 30 CRYOABLATION EP CATHETERS MARKET, BY REGION, 2019–2027 (USD MILLION) 98 6.3.2 RADIOFREQUENCY (RF) ABLATION CATHETERS 98 6.3.2.1 Technological advancements in radiofrequency ablation catheters to drive the market 98 TABLE 31 RF ABLATION CATHETERS MARKET, BY REGION, 2019–2027 (USD MILLION) 99 6.3.3 MICROWAVE ABLATION (MWA) SYSTEMS 99 6.3.3.1 Advantages of Microwave Ablation Systems over RF Ablation Catheters to drive market growth 99 TABLE 32 MWA SYSTEMS MARKET, BY REGION, 2019–2027 (USD MILLION) 101 6.3.4 LASER ABLATION SYSTEMS 101 6.3.4.1 Technologically advanced products to drive market growth 101 TABLE 33 LASER ABLATION SYSTEMS MARKET, BY REGION, 2019–2027 (USD MILLION) 102 6.4 ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS 102 TABLE 34 EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION) 102 TABLE 35 EP DIAGNOSTIC CATHETERS MARKET, BY INDICATION, 2019–2027 (USD MILLION) 103 TABLE 36 EP DIAGNOSTIC CATHETERS MARKET, BY END USER, 2019–2027 (USD MILLION) 103 TABLE 37 EP DIAGNOSTIC CATHETERS MARKET, BY REGION, 2019–2027 (USD MILLION) 104 6.4.1 CONVENTIONAL ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS 104 6.4.1.1 Increasing demand in emerging markets to support market growth 104 TABLE 38 CONVENTIONAL EP DIAGNOSTIC CATHETERS MARKET, BY REGION, 2019–2027 (USD MILLION) 105 6.4.2 ADVANCED ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS 105 6.4.2.1 Advantages of Advanced Electrophysiology Diagnostic Catheters over conventional EP diagnostic catheters to drive market growth 105 TABLE 39 ADVANCED EP DIAGNOSTIC CATHETERS MARKET, BY REGION, 2019–2027 (USD MILLION) 106 6.4.3 ULTRASOUND ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS 106 6.4.3.1 Increased demand due to rising use of ICE ultrasound imaging systems to drive market growth 106 TABLE 40 ULTRASOUND EP DIAGNOSTIC CATHETERS MARKET, BY REGION, 2019–2027 (USD MILLION) 107 6.5 ACCESS DEVICES 107 6.5.1 LAUNCH OF TECHNOLOGICALLY ADVANCED PRODUCTS TO DRIVE MARKET GROWTH 107 TABLE 41 ACCESS DEVICES MARKET, BY INDICATION, 2019–2027 (USD MILLION) 108 TABLE 42 ACCESS DEVICES MARKET, BY END USER, 2019–2027 (USD MILLION) 108 TABLE 43 ACCESS DEVICES MARKET, BY REGION, 2019–2027 (USD MILLION) 109 6.6 OTHER PRODUCTS 109 TABLE 44 OTHER PRODUCTS MARKET, BY INDICATION, 2019–2027 (USD MILLION) 109 TABLE 45 OTHER PRODUCTS MARKET, BY END USER, 2019–2027 (USD MILLION) 110 TABLE 46 OTHER PRODUCTS MARKET, BY REGION, 2019–2027 (USD MILLION) 110 7 ELECTROPHYSIOLOGY MARKET, BY INDICATION TYPE 111 7.1 INTRODUCTION 112 TABLE 47 ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2019–2027 (USD MILLION) 112 7.2 ATRIAL FIBRILLATION 112 7.2.1 GROWING INITIATIVES TO SHOWCASE ADVANTAGES OF CATHETER ABLATION OVER ANTIARRHYTHMIC DRUGS TO DRIVE MARKET GROWTH 112 TABLE 48 ELECTROPHYSIOLOGY MARKET FOR ATRIAL FIBRILLATION, BY REGION, 2019–2027 (USD MILLION) 113 7.3 ATRIAL FLUTTER 114 7.3.1 HIGH SUCCESS RATE OF RADIOFREQUENCY CATHETER ABLATION FOR TREATMENT OF ATRIAL FLUTTER TO DRIVE MARKET GROWTH 114 TABLE 49 ELECTROPHYSIOLOGY MARKET FOR ATRIAL FLUTTER, BY REGION, 2019–2027 (USD MILLION) 114 7.4 ATRIOVENTRICULAR NODAL REENTRY TACHYCARDIA (AVNRT) 115 7.4.1 INCREASING VALIDATION OF EFFICACY OF ELECTROPHYSIOLOGY DEVICES FOR AVNRT TO DRIVE MARKET GROWTH 115 TABLE 50 ELECTROPHYSIOLOGY MARKET FOR ATRIOVENTRICULAR NODAL REENTRY TACHYCARDIA, BY REGION, 2019–2027 (USD MILLION) 115 7.5 WOLFF-PARKINSON-WHITE SYNDROME (WPW) 116 7.5.1 PREFERENCE FOR RADIOFREQUENCY ABLATION OVER SURGERY TO TREAT WOLFF-PARKINSON-WHITE SYNDROME TO DRIVE MARKET GROWTH 116 TABLE 51 ELECTROPHYSIOLOGY MARKET FOR WOLFF-PARKINSON-WHITE SYNDROME, BY REGION, 2019–2027 (USD MILLION) 116 7.6 OTHER INDICATIONS 117 TABLE 52 ELECTROPHYSIOLOGY MARKET FOR OTHER INDICATIONS, BY REGION, 2019–2027 (USD MILLION) 117 8 ELECTROPHYSIOLOGY MARKET, BY END USER 118 8.1 INTRODUCTION 119 TABLE 53 ELECTROPHYSIOLOGY MARKET, BY END USER, 2019–2027 (USD MILLION) 119 8.2 HOSPITALS & CARDIAC CENTERS 119 8.2.1 HOSPITAL & CARDIAC CENTERS TO DOMINATE END USER SEGMENT 119 TABLE 54 ELECTROPHYSIOLOGY MARKET FOR HOSPITALS & CARDIAC CENTERS, BY REGION, 2019–2027 (USD MILLION) 120 8.3 AMBULATORY SURGERY CENTERS 120 8.3.1 INCREASING NUMBER OF AMBULATORY SURGICAL CENTERS IN THE US TO DRIVE ADOPTION OF ELECTROPHYSIOLOGY DEVICES 120 TABLE 55 ELECTROPHYSIOLOGY MARKET FOR AMBULATORY SURGERY CENTERS, BY REGION, 2019–2027 (USD MILLION) 121 9 ELECTROPHYSIOLOGY MARKET, BY REGION 122 9.1 INTRODUCTION 123 FIGURE 24 GEOGRAPHIC SNAPSHOT OF ELECTROPHYSIOLOGY MARKET 123 TABLE 56 ELECTROPHYSIOLOGY MARKET, BY REGION, 2019–2027 (USD MILLION) 124 9.2 NORTH AMERICA 125 FIGURE 25 NORTH AMERICA: ELECTROPHYSIOLOGY MARKET SNAPSHOT 125 TABLE 57 NORTH AMERICA: ELECTROPHYSIOLOGY MARKET, BY COUNTRY, 2019–2027 (USD MILLION) 126 TABLE 58 NORTH AMERICA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2019–2027 (USD MILLION) 126 TABLE 59 NORTH AMERICA: EP LABORATORY DEVICES MARKET, BY TYPE, 2019–2027 (USD MILLION) 127 TABLE 60 NORTH AMERICA: EP ABLATION CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION) 127 TABLE 61 NORTH AMERICA: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION) 128 TABLE 62 NORTH AMERICA: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2019–2027 (USD MILLION) 128 TABLE 63 NORTH AMERICA: ELECTROPHYSIOLOGY MARKET, BY END USER, 2019–2027 (USD MILLION) 129 9.2.1 US 129 9.2.1.1 Technological advancements to drive market growth 129 TABLE 64 CLINICAL TRIALS RELATED TO ELECTROPHYSIOLOGY DEVICES 130 TABLE 65 US: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2019–2027 (USD MILLION) 131 TABLE 66 US: EP LABORATORY DEVICES MARKET, BY TYPE, 2019–2027 (USD MILLION) 131 TABLE 67 US: EP ABLATION CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION) 132 TABLE 68 US: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION) 132 9.2.2 CANADA 133 9.2.2.1 Growing government funding for research to support market growth 133 TABLE 69 RESEARCH GRANTS TOWARDS RESEARCH IN CARDIOLOGY 134 TABLE 70 CANADA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2019–2027 (USD MILLION) 135 TABLE 71 CANADA: EP LABORATORY DEVICES MARKET, BY TYPE, 2019–2027 (USD MILLION) 135 TABLE 72 CANADA: EP ABLATION CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION) 136 TABLE 73 CANADA: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION) 136 9.3 EUROPE 137 TABLE 74 EUROPE: ELECTROPHYSIOLOGY MARKET, BY COUNTRY, 2019–2027 (USD MILLION) 137 TABLE 75 EUROPE: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2019–2027 (USD MILLION) 138 TABLE 76 EUROPE: EP LABORATORY DEVICES MARKET, BY TYPE, 2019–2027 (USD MILLION) 138 TABLE 77 EUROPE: EP ABLATION CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION) 139 TABLE 78 EUROPE: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION) 139 TABLE 79 EUROPE: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2019–2027 (USD MILLION) 140 TABLE 80 EUROPE: ELECTROPHYSIOLOGY MARKET, BY END USER, 2019–2027 (USD MILLION) 140 9.3.1 GERMANY 141 9.3.1.1 Rising healthcare expenditure and growing use of electrophysiology devices to drive market growth 141 TABLE 81 GERMANY: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2019–2027 (USD MILLION) 141 TABLE 82 GERMANY: EP LABORATORY DEVICES MARKET, BY TYPE, 2019–2027 (USD MILLION) 142 TABLE 83 GERMANY: EP ABLATION CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION) 142 TABLE 84 GERMANY: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION) 143 9.3.2 UK 143 9.3.2.1 Growing geriatric population to drive market growth 143 TABLE 85 UK: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2019–2027 (USD MILLION) 144 TABLE 86 UK: EP LABORATORY DEVICES MARKET, BY TYPE, 2019–2027 (USD MILLION) 144 TABLE 87 UK: EP ABLATION CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION) 145 TABLE 88 UK: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION) 145 9.3.3 FRANCE 146 9.3.3.1 Increasing incidence of heart failure to support market growth 146 TABLE 89 FRANCE: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2019–2027 (USD MILLION) 146 TABLE 90 FRANCE: EP LABORATORY DEVICES MARKET, BY TYPE, 2019–2027 (USD MILLION) 147 TABLE 91 FRANCE: EP ABLATION CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION) 147 TABLE 92 FRANCE: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION) 148 9.3.4 ITALY 148 9.3.4.1 Rising incidence of CVDs to drive electrophysiology devices adoption 148 TABLE 93 ITALY: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2019–2027 (USD MILLION) 149 TABLE 94 ITALY: EP LABORATORY DEVICES MARKET, BY TYPE, 2019–2027 (USD MILLION) 149 TABLE 95 ITALY: EP ABLATION CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION) 150 TABLE 96 ITALY: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION) 150 9.3.5 SPAIN 151 9.3.5.1 Growing number of cardiac ablation procedures to drive market growth 151 TABLE 97 SPAIN: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2019–2027 (USD MILLION) 151 TABLE 98 SPAIN: EP LABORATORY DEVICES MARKET, BY TYPE, 2019–2027 (USD MILLION) 152 TABLE 99 SPAIN: EP ABLATION CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION) 152 TABLE 100 SPAIN: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION) 153 9.3.6 REST OF EUROPE 153 TABLE 101 CARDIAC AF ABLATION PROCEDURES, BY COUNTRY, 2015 VS. 2016 154 TABLE 102 ROE: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2019–2027 (USD MILLION) 154 TABLE 103 ROE: EP LABORATORY DEVICES MARKET, BY TYPE, 2019–2027 (USD MILLION) 155 TABLE 104 ROE: EP ABLATION CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION) 155 TABLE 105 ROE: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION) 156 9.4 ASIA PACIFIC 156 FIGURE 26 ASIA PACIFIC: ELECTROPHYSIOLOGY MARKET SNAPSHOT 157 TABLE 106 ASIA PACIFIC: ELECTROPHYSIOLOGY MARKET, BY COUNTRY, 2019–2027 (USD MILLION) 158 TABLE 107 ASIA PACIFIC: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2019–2027 (USD MILLION) 158 TABLE 108 ASIA PACIFIC: EP LABORATORY DEVICES MARKET, BY TYPE, 2019–2027 (USD MILLION) 159 TABLE 109 ASIA PACIFIC: EP ABLATION CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION) 159 TABLE 110 ASIA PACIFIC: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION) 160 TABLE 111 ASIA PACIFIC: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2019–2027 (USD MILLION) 160 TABLE 112 ASIA PACIFIC: ELECTROPHYSIOLOGY MARKET, BY END USER, 2019–2027 (USD MILLION) 161 9.4.1 JAPAN 161 9.4.1.1 Favorable reimbursement scenario to support market growth 161 TABLE 113 JAPAN: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2019–2027 (USD MILLION) 162 TABLE 114 JAPAN: EP LABORATORY DEVICES MARKET, BY TYPE, 2019–2027 (USD MILLION) 162 TABLE 115 JAPAN: EP ABLATION CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION) 163 TABLE 116 JAPAN: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION) 163 9.4.2 CHINA 164 9.4.2.1 Growing geriatric population to drive market growth 164 TABLE 117 CHINA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2019–2027 (USD MILLION) 164 TABLE 118 CHINA: EP LABORATORY DEVICES MARKET, BY TYPE, 2019–2027 (USD MILLION) 165 TABLE 119 CHINA: EP ABLATION CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION) 165 TABLE 120 CHINA: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION) 166 9.4.3 INDIA 166 9.4.3.1 Increasing healthcare initiatives by government to drive market growth 166 TABLE 121 INDIA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2019–2027 (USD MILLION) 167 TABLE 122 INDIA: EP LABORATORY DEVICES MARKET, BY TYPE, 2019–2027 (USD MILLION) 167 TABLE 123 INDIA: EP ABLATION CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION) 168 TABLE 124 INDIA: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION) 168 9.4.4 AUSTRALIA 169 9.4.4.1 Increasing target disease burden to support market growth 169 TABLE 125 AUSTRALIA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2019–2027 (USD MILLION) 169 TABLE 126 AUSTRALIA: EP LABORATORY DEVICES MARKET, BY TYPE, 2019–2027 (USD MILLION) 170 TABLE 127 AUSTRALIA: EP ABLATION CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION) 170 TABLE 128 AUSTRALIA: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION) 171 9.4.5 SOUTH KOREA 171 9.4.5.1 Supportive government initiatives to drive market growth 171 TABLE 129 SOUTH KOREA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2019–2027 (USD MILLION) 172 TABLE 130 SOUTH KOREA: EP LABORATORY DEVICES MARKET, BY TYPE, 2019–2027 (USD MILLION) 172 TABLE 131 SOUTH KOREA: EP ABLATION CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION) 173 TABLE 132 SOUTH KOREA: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION) 173 9.4.6 REST OF ASIA PACIFIC 173 TABLE 133 ROAPAC: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2019–2027 (USD MILLION) 174 TABLE 134 ROAPAC: EP LABORATORY DEVICES MARKET, BY TYPE, 2019–2027 (USD MILLION) 175 TABLE 135 ROAPAC: EP ABLATION CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION) 175 TABLE 136 ROAPAC: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION) 176 9.5 LATIN AMERICA 176 TABLE 137 LATAM: ELECTROPHYSIOLOGY MARKET, BY COUNTRY, 2019–2027 (USD MILLION) 177 TABLE 138 LATAM: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2019–2027 (USD MILLION) 177 TABLE 139 LATAM: EP LABORATORY DEVICES MARKET, BY TYPE, 2019–2027 (USD MILLION) 178 TABLE 140 LATAM: EP ABLATION CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION) 178 TABLE 141 LATAM: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION) 179 TABLE 142 LATAM: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2019–2027 (USD MILLION) 179 TABLE 143 LATAM: ELECTROPHYSIOLOGY MARKET, BY END USER, 2019–2027 (USD MILLION) 180 9.5.1 BRAZIL 180 9.5.1.1 Modernization of healthcare facilities to drive market growth 180 TABLE 144 BRAZIL: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2019–2027 (USD MILLION) 181 TABLE 145 BRAZIL: EP LABORATORY DEVICES MARKET, BY TYPE, 2019–2027 (USD MILLION) 181 TABLE 146 BRAZIL: EP ABLATION CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION) 182 TABLE 147 BRAZIL: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION) 182 9.5.2 MEXICO 183 9.5.2.1 Favorable investment scenario for medical device manufacturers to drive market growth 183 TABLE 148 MEXICO: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2019–2027 (USD MILLION) 183 TABLE 149 MEXICO: EP LABORATORY DEVICES MARKET, BY TYPE, 2019–2027 (USD MILLION) 184 TABLE 150 MEXICO: EP ABLATION CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION) 184 TABLE 151 MEXICO: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION) 185 9.5.3 REST OF LATIN AMERICA 185 TABLE 152 ROLA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2019–2027 (USD MILLION) 185 TABLE 153 ROLA: EP LABORATORY DEVICES MARKET, BY TYPE, 2019–2027 (USD MILLION) 186 TABLE 154 ROLA: EP ABLATION CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION) 186 TABLE 155 ROLA: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION) 187 9.6 MIDDLE EAST & AFRICA 187 TABLE 156 MEA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2019–2027 (USD MILLION) 188 TABLE 157 MEA: EP LABORATORY DEVICES MARKET, BY TYPE, 2019–2027 (USD MILLION) 188 TABLE 158 MEA: EP ABLATION CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION) 189 TABLE 159 MEA: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2019–2027 (USD MILLION) 189 TABLE 160 MEA: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2019–2027 (USD MILLION) 190 TABLE 161 MEA: ELECTROPHYSIOLOGY MARKET, BY END USER, 2019–2027 (USD MILLION) 190 10 COMPETITIVE LANDSCAPE 191 10.1 INTRODUCTION 191 FIGURE 27 KEY DEVELOPMENTS BY LEADING PLAYERS IN ELECTROPHYSIOLOGY MARKET, 2018–2021 191 10.2 REVENUE SHARE ANALYSIS 192 FIGURE 28 REVENUE SHARE ANALYSIS OF TOP PLAYERS IN ELECTROPHYSIOLOGY MARKET 192 10.3 MARKET SHARE ANALYSIS 193 FIGURE 29 ELECTROPHYSIOLOGY MARKET SHARE, BY KEY PLAYER, 2020 193 TABLE 162 ELECTROPHYSIOLOGY MARKET: DEGREE OF COMPETITION 193 10.4 COMPETITIVE LEADERSHIP MAPPING: COMPANY EVALUATION QUADRANT (2020) 195 10.4.1 STARS 195 10.4.2 EMERGING LEADERS 195 10.4.3 PERVASIVE PLAYERS 195 10.4.4 PARTICIPANTS 195 FIGURE 30 ELECTROPHYSIOLOGY MARKET: COMPETITIVE LEADERSHIP MAPPING (2020) 196 10.5 COMPETITIVE LEADERSHIP MAPPING: START-UP/SME EVALUATION QUADRANT (AS OF 2020) 197 10.5.1 PROGRESSIVE COMPANIES 197 10.5.2 RESPONSIVE COMPANIES 197 10.5.3 DYNAMIC COMPANIES 197 10.5.4 STARTING BLOCKS 197 FIGURE 31 ELECTROPHYSIOLOGY MARKET: COMPETITIVE LEADERSHIP MAPPING (SMES/START-UPS) (2020) 198 10.6 COMPETITIVE BENCHMARKING 199 TABLE 163 PRODUCT FOOTPRINT ANALYSIS OF TOP PLAYERS IN ELECTROPHYSIOLOGY MARKET 199 TABLE 164 COMPANY FOOTPRINT ANALYSIS IN ELECTROPHYSIOLOGY MARKET 200 10.7 COMPETITIVE SCENARIO (2018–2021) 201 10.7.1 PRODUCT LAUNCHES 201 10.7.2 APPROVALS 202 10.7.3 DEALS 204 11 COMPANY PROFILES 208 11.1 KEY PLAYERS 208 (Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))* 11.1.1 ABBOTT 208 TABLE 165 ABBOTT: BUSINESS OVERVIEW 208 FIGURE 32 ABBOTT: COMPANY SNAPSHOT (2020) 209 11.1.2 MEDTRONIC 214 TABLE 166 MEDTRONIC: BUSINESS OVERVIEW 214 FIGURE 33 MEDTRONIC: COMPANY SNAPSHOT (2021) 215 11.1.3 BOSTON SCIENTIFIC CORPORATION 220 TABLE 167 BOSTON SCIENTIFIC CORPORATION: BUSINESS OVERVIEW 220 FIGURE 34 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2020) 221 11.1.4 KONINKLIJKE PHILIPS N.V. 227 TABLE 168 KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW 227 FIGURE 35 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2020) 228 11.1.5 GE HEALTHCARE 231 TABLE 169 GE HEALTHCARE: BUSINESS OVERVIEW 231 FIGURE 36 GE HEALTHCARE: COMPANY SNAPSHOT (2020) 232 11.1.6 SIEMENS HEALTHINEERS 234 TABLE 170 SIEMENS HEALTHINEERS: BUSINESS OVERVIEW 234 FIGURE 37 SIEMENS HEALTHINEERS: COMPANY SNAPSHOT (2020) 235 11.1.7 STEREOTAXIS, INC. 237 TABLE 171 STEREOTAXIS, INC.: BUSINESS OVERVIEW 237 FIGURE 38 STEREOTAXIS: COMPANY SNAPSHOT (2020) 238 11.1.8 MERIT MEDICAL SYSTEMS 241 TABLE 172 MERIT MEDICAL SYSTEMS: BUSINESS OVERVIEW 241 FIGURE 39 MERIT MEDICAL SYSTEMS: COMPANY SNAPSHOT (2020) 242 11.1.9 ATRICURE INC. 243 TABLE 173 ATRICURE, INC.: BUSINESS OVERVIEW 243 FIGURE 40 ATRICURE, INC.: COMPANY SNAPSHOT (2020) 244 11.1.10 APN HEALTH, LLC 246 TABLE 174 APN HEALTH, LLC: BUSINESS OVERVIEW 246 11.1.11 OSYPKA MEDICAL 247 TABLE 175 OSYPKA MEDICAL: BUSINESS OVERVIEW 247 11.1.12 JAPAN LIFELINE CO., LTD. 249 TABLE 176 JAPAN LIFELINE CO., LTD.: BUSINESS OVERVIEW 249 FIGURE 41 JAPAN LIFELINE CO., LTD.: COMPANY SNAPSHOT (2020) 249 11.1.13 JOHNSON & JOHNSON 251 TABLE 177 JOHNSON & JOHNSON: BUSINESS OVERVIEW 251 FIGURE 42 JOHNSON & JOHNSON: COMPANY SNAPSHOT (2020) 252 11.1.14 BIOTRONIK 258 TABLE 178 BIOTRONIK: BUSINESS OVERVIEW 258 11.1.15 MICROPORT SCIENTIFIC CORPORATION 262 TABLE 179 MICROPORT SCIENTIFIC CORPORATION: BUSINESS OVERVIEW 262 FIGURE 43 MICROPORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2020) 263 11.1.16 ACUTUS MEDICAL, INC. 265 TABLE 180 ACUTUS MEDICAL, INC.: BUSINESS OVERVIEW 265 FIGURE 44 ACUTUS MEDICAL INC.: COMPANY SNAPSHOT (2020) 266 11.2 OTHER PLAYERS 269 11.2.1 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD. 269 11.2.2 CATHRX LTD. 270 11.2.3 COOK MEDICAL 271 11.2.4 CATHVISION APS 272 11.2.5 TZ MEDICAL 273 11.2.6 TELEFLEX INCORPORATED 274 11.2.7 IMRICOR 275 11.2.8 CARDIOFOCUS 276 11.2.9 SCHWARZER CARDIOTEK GMBH 277 11.2.10 KARDIUM 278 11.2.11 EP SOLUTIONS SA 279 11.2.12 BIOSIG TECHNOLOGIES, INC. (BSGM) 280 11.2.13 COREMAP 281 11.2.14 EPMAP SYSTEM GMBH 282 *Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies. 12 APPENDIX 283 12.1 DISCUSSION GUIDE 283 12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 288 12.3 AVAILABLE CUSTOMIZATIONS 290 12.4 RELATED REPORTS 290 12.5 AUTHOR DETAILS 291
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(その他)の最新刊レポート
MarketsandMarkets 社の最新刊レポート
本レポートと同じKEY WORD(devices)の最新刊レポート
よくあるご質問MarketsandMarkets社はどのような調査会社ですか?マーケッツアンドマーケッツ(MarketsandMarkets)は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/07 10:27 155.63 円 167.26 円 203.27 円 |